Signup Crypto ETF Stocks News

Calamos Announces Cap Ranges of Principal Protected Bitcoin ETFs April Series on the Heels of a Successful Inaugural Launch

METRO CHICAGO, Ill., March 31, 2025 /PRNewswire/ -- John Koudounis, President and CEO of Calamos, announced the planned April launch of the three new ETFs in the World's First Downside Protected Bitcoin ETF Suite, offering Bitcoin upside growth with 100% ( CBOA ) , 90% ( CBXA ) , and 80% ( CBTA ...

Source: www.benzinga.com
March 31, 2025 | 11:30:00
Category: News

Westhaven Announces Leadership Changes; Appoints Armstrong President & CEO

VANCOUVER, British Columbia, March 31, 2025 ( GLOBE NEWSWIRE ) -- Westhaven Gold Corp. ( TSX-V:WHN ) today announced that Gareth Thomas will step down as President and Chief Executive Officer, effective April 30, 2025 with the Board of Directors appointing Ken Armstrong as the new President and ...

Source: www.globenewswire.com
March 31, 2025 | 11:30:00
Category: News

Is AppLovin Stock a Buy?

Advertising tech firm AppLovin ( NASDAQ: APP ) saw its stock soar over the past year. Shares skyrocketed nearly 300% over the past 12 months.But this hot stock has been on the decline since it peaked in February, when it hit a 52-week high of $525.15.

Source: www.fool.com
March 31, 2025 | 11:30:00
Category: News

Palvella Therapeutics Reports Full Year 2024 Financial Results and Provides Corporate Update

Upon close of merger and $78.9mm concurrent private placement from a syndicate of leading healthcare-dedicated investors, completed transformation to a publicly traded rare disease biopharmaceutical company advancing a late clinical-stage pipeline and a platform for treating serious, rare ...

Source: www.globenewswire.com
March 31, 2025 | 11:30:00
Category: News

Anavex Life Sciences to Present at the 24th Annual Needham Virtual Healthcare Conference

NEW YORK, March 31, 2025 ( GLOBE NEWSWIRE ) -- Anavex Life Sciences Corp. ( "Anavex" or the "Company" ) ( Nasdaq: AVXL ) , a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, ...

Source: www.globenewswire.com
March 31, 2025 | 11:30:00
Category: News

Revival Gold Delivers Compelling PEA Results and Attractive Potential Re-development Timeline for the Mercur Gold Project

TORONTO, March 31, 2025 ( GLOBE NEWSWIRE ) -- Revival Gold Inc. ( TSXV: RVG, OTCQX: RVLGF ) ( "Revival Gold" or the "Company" ) is pleased to announce compelling results from a Preliminary Economic Assessment ( "PEA" ) on the Company's Mercur Gold Project ( "Mercur" or the "Project" ) in Utah, ...

Source: www.globenewswire.com
March 31, 2025 | 11:30:00
Category: News

CONNOR CLARK & LUNN FUNDS INC. LAUNCHES PCJ FOCUSED OPPORTUNITIES FUND AS LIQUID ALTERNATIVE, CC&L ALTERNATIVE INCOME FUND RENAMED AS CC&L ABSOLUTE RETURN BOND FUND

TORONTO, March 31, 2025 /CNW/ - Connor, Clark & Lunn Funds Inc. ( "CC&L Funds" ) is excited to provide an update on two liquid alternative funds: the launch of the PCJ Focused Opportunities Fund, and the renaming of CC&L Alternative Income Fund to CC&L Absolute Return Bond Fund ( collectively, ...

Source: www.benzinga.com
March 31, 2025 | 11:30:00
Category: News

FTI Consulting Announces Election of Eric Steigerwalt and Janet Zelenka as Independent Directors - FTI Consulting ( NYSE:FCN )

WASHINGTON, March 31, 2025 ( GLOBE NEWSWIRE ) -- FTI Consulting, Inc. FCN today announced that its Board of Directors elected Eric T. Steigerwalt and Janet H. Zelenka as independent directors of the Company, effective March 25, 2025, following the action of the Board to increase its overall size ...

Source: www.benzinga.com
March 31, 2025 | 11:30:00
Category: News

Gold Nanoparticles Market worth $1.11 billion in 2029, at a 16.3%, says MarketsandMarkets™

Delray Beach, FL, March 31, 2025 ( GLOBE NEWSWIRE ) -- In terms of value, the Gold Nanoparticles Market size is expected to reach USD 1.11 billion in 2029 from USD 0.50 billion in 2024, at a CAGR of 16.3%, as per the recent study by MarketsandMarkets™.

Source: www.benzinga.com
March 31, 2025 | 11:30:00
Category: News

Anavex Life Sciences to Present at the 24th Annual Needham Virtual Healthcare Conference - Anavex Life Sciences ( NASDAQ:AVXL )

NEW YORK, March 31, 2025 ( GLOBE NEWSWIRE ) -- Anavex Life Sciences Corp. ( "Anavex" or the "Company" ) AVXL, a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, ...

Source: www.benzinga.com
March 31, 2025 | 11:30:00
Category: News

© Natavest 2025 - 2026